# Kline Vision Canonical URL: https://klinevision.ai/ Kline Vision is an AI-powered stock K-line technical analysis web product for A-share and US-stock chart screenshots. The product is stock-first: public positioning focuses on A-share and US-stock candlestick chart review, not broad multi-asset marketing. It helps users turn candlestick chart screenshots into structured AI Technical Analysis covering trend, indicators, key levels, support and resistance, patterns, signals, setup context, risk notes, and next-step review context. Chan Theory remains available as an optional Advanced Structure layer for expert users who want Bi, Duan, Zhongshu, and Beichi context. ## Supported Markets - A-shares - US stocks ## Unsupported Current Markets - Crypto is not current public positioning or support. - Web3 is not current public positioning or support. - Gold is not current public positioning or support. ## Core Use Cases - Upload an A-share or US-stock candlestick screenshot for structured technical-analysis review. - Add a symbol and timeframe when available to enrich the chart read with market context. - Review trend, indicators, support and resistance, chart patterns, setup context, and risk notes. - Save analyses, share result links, open chart context, add another timeframe, and create stock alerts where available. - Use Advanced Structure when Chan Theory concepts matter to the review. ## Data Context Market context depends on configured providers and available data. A-share context can use Tushare, and US-stock context can use EODHD or Finnhub fallback where configured. If provider data is unavailable, Kline Vision should mark the context unavailable instead of fabricating metrics. ## Important Limits Kline Vision is for educational and research purposes only. It is not investment advice. Markets involve risk, and users are responsible for their own decisions. It does not promise returns, audited accuracy, prediction, or buy/sell recommendations. This file is an informational source summary for crawlers and assistants; it is not a ranking, traffic, citation, or indexing guarantee. ## Pilot Educational Pages Supported pilot pages are educational EN/ZH indicator and pattern references. English URLs are unprefixed, and Chinese URLs use /zh with the same slugs. - indicator: https://klinevision.ai/indicators/rsi/ and https://klinevision.ai/zh/indicators/rsi/ - indicator: https://klinevision.ai/indicators/macd/ and https://klinevision.ai/zh/indicators/macd/ - indicator: https://klinevision.ai/indicators/bollinger-bands/ and https://klinevision.ai/zh/indicators/bollinger-bands/ - indicator: https://klinevision.ai/indicators/ema/ and https://klinevision.ai/zh/indicators/ema/ - indicator: https://klinevision.ai/indicators/sma/ and https://klinevision.ai/zh/indicators/sma/ - indicator: https://klinevision.ai/indicators/adx/ and https://klinevision.ai/zh/indicators/adx/ - pattern: https://klinevision.ai/patterns/head-and-shoulders/ and https://klinevision.ai/zh/patterns/head-and-shoulders/ - pattern: https://klinevision.ai/patterns/inverse-head-and-shoulders/ and https://klinevision.ai/zh/patterns/inverse-head-and-shoulders/ - pattern: https://klinevision.ai/patterns/double-top/ and https://klinevision.ai/zh/patterns/double-top/ - pattern: https://klinevision.ai/patterns/double-bottom/ and https://klinevision.ai/zh/patterns/double-bottom/ - pattern: https://klinevision.ai/patterns/ascending-triangle/ and https://klinevision.ai/zh/patterns/ascending-triangle/ - pattern: https://klinevision.ai/patterns/descending-triangle/ and https://klinevision.ai/zh/patterns/descending-triangle/ ## Key URLs - Home: https://klinevision.ai/ - Pricing: https://klinevision.ai/pricing - About: https://klinevision.ai/about - Disclaimer: https://klinevision.ai/disclaimer - Data sources: https://klinevision.ai/data-sources - Sitemap: https://klinevision.ai/sitemap.xml - Chinese home: https://klinevision.ai/zh ## Source Boundary This summary is based on the project README, product marketing context, and positioning guide. It should not be treated as customer research, a legal policy, or a provider availability guarantee.